Peptide-based and small molecule PD-1 and PD-L1 pharmacological modulators in the treatment of cancer

Por Islam, Mohammad Kaisarul, Stanslas, Johnson
Publicado em 2021

Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?

Por Hamdi, Amir Imran Faisal, Soon, Hin How, Islam, Mohammad Kaisarul, Chee, Jonathan Woei Lim, Stanslas, Johnson
Publicado em 2022

Pharmacological modulation of apoptosis and autophagy in pancreatic cancer treatment

Por Stanslas, Johnson, Islam, Mohammad Kaisarul, Selvarajoo, Nityaa, Sagineedu, Sreenivasa Rao, Lian, Ho Kok, Lim, Jonathan Chee Woei
Publicado em 2022

The impact of cycleanine in cancer research: a computational study

Por Nwaefulu, Ogochukwu Ngozi, Al-Shar'i, Nizar A, Owolabi, Josephine Omonkhelin, Sagineedu, Sreenivasa Rao, Lim, Chee Woei, Lam, Kok Wai, Islam, Mohammad Kaisarul, Jayanthi, Sivaraman, Stanslas, Johnson
Publicado em 2022